Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satishkumar Mohanavelu

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
The American Journal of Cardiology|July 7, 2009
Safety and efficacy of achieving very low low-density lipoprotein cholesterol levels with rosuvastatin 40 mg daily (from the ASTEROID Study)Stephen D Wiviott, Satishkumar Mohanavelu, Joel S Raichlen, et al.
Journal of the American College of Cardiology|June 21, 2008
Thrombus precursor protein and clinical outcomes in patients with acute coronary syndromesJessica L Mega, David A Morrow, James A de Lemos, et al.
Journal of the American College of Cardiology|September 6, 2008
Baseline low-density lipoprotein cholesterol is an important predictor of the benefit of intensive lipid-lowering therapy: a PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) analysisRoberto R Giraldez, Robert P Giugliano, Satishkumar Mohanavelu, et al.
American Heart Journal|March 3, 2009
Baseline hemoglobin concentration and creatinine clearance composite laboratory index improves risk stratification in ST-elevation myocardial infarctionRoberto R Giraldez, Marc S Sabatine, David A Morrow, et al.
The American Journal of Cardiology|August 21, 2010
Relation between infarct size in ST-segment elevation myocardial infarction treated successfully by percutaneous coronary intervention and left ventricular ejection fraction three months after the infarctYuri B Pride, Jennifer L Giuseffi, Satishkumar Mohanavelu, et al.
The American Journal of Medicine|November 3, 2007
TIMI risk index and the benefit of enoxaparin in patients with ST-elevation myocardial infarctionChristian T Ruff, Stephen D Wiviott, David A Morrow, et al.
Drugs|July 29, 2009
Streptokinase and enoxaparin as an alternative to fibrin-specific lytic-based regimens: an ExTRACT-TIMI 25 analysisRoberto R Giraldez, Stephen D Wiviott, Jose C Nicolau, et al.
JAMA|August 21, 2007
Diabetes and mortality following acute coronary syndromesSean M Donahoe, Garrick C Stewart, Carolyn H McCabe, et al.
Chronobiology International|November 8, 2012
Circadian variation in patient characteristics and outcomes in ST-segment elevation myocardial infarctionOwen Mogabgab, Robert P Giugliano, Marc S Sabatine, et al.
The American Journal of Cardiology|May 2, 2009
Predicting irreversible left ventricular dysfunction after acute myocardial infarctionDaniel R Frisch, Evaldas Giedrimas, Satishkumar Mohanavelu, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
The American Journal of Cardiology|July 7, 2009
Safety and efficacy of achieving very low low-density lipoprotein cholesterol levels with rosuvastatin 40 mg daily (from the ASTEROID Study)Stephen D Wiviott, Satishkumar Mohanavelu, Joel S Raichlen, et al.
Journal of the American College of Cardiology|June 21, 2008
Thrombus precursor protein and clinical outcomes in patients with acute coronary syndromesJessica L Mega, David A Morrow, James A de Lemos, et al.
Journal of the American College of Cardiology|September 6, 2008
Baseline low-density lipoprotein cholesterol is an important predictor of the benefit of intensive lipid-lowering therapy: a PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) analysisRoberto R Giraldez, Robert P Giugliano, Satishkumar Mohanavelu, et al.
American Heart Journal|March 3, 2009
Baseline hemoglobin concentration and creatinine clearance composite laboratory index improves risk stratification in ST-elevation myocardial infarctionRoberto R Giraldez, Marc S Sabatine, David A Morrow, et al.
The American Journal of Cardiology|August 21, 2010
Relation between infarct size in ST-segment elevation myocardial infarction treated successfully by percutaneous coronary intervention and left ventricular ejection fraction three months after the infarctYuri B Pride, Jennifer L Giuseffi, Satishkumar Mohanavelu, et al.
The American Journal of Medicine|November 3, 2007
TIMI risk index and the benefit of enoxaparin in patients with ST-elevation myocardial infarctionChristian T Ruff, Stephen D Wiviott, David A Morrow, et al.
Drugs|July 29, 2009
Streptokinase and enoxaparin as an alternative to fibrin-specific lytic-based regimens: an ExTRACT-TIMI 25 analysisRoberto R Giraldez, Stephen D Wiviott, Jose C Nicolau, et al.
JAMA|August 21, 2007
Diabetes and mortality following acute coronary syndromesSean M Donahoe, Garrick C Stewart, Carolyn H McCabe, et al.
Chronobiology International|November 8, 2012
Circadian variation in patient characteristics and outcomes in ST-segment elevation myocardial infarctionOwen Mogabgab, Robert P Giugliano, Marc S Sabatine, et al.
The American Journal of Cardiology|May 2, 2009
Predicting irreversible left ventricular dysfunction after acute myocardial infarctionDaniel R Frisch, Evaldas Giedrimas, Satishkumar Mohanavelu, et al.
Pageof 2